Part D/Prescription Drugs – Page 14

Friday, December 5, 2025

Latest:

Eileen Cook December 23, 2024December 23, 2024 FDA, sleep apnea, Weight-loss drugs, Zepbound

FDA approves weight loss drug Zepbound to treat obstructive sleep apnea

(By Juliana Kim for NPR) The weight loss drug Zepbound has become the first prescription medication approved to treat obstructive

Aging Part D/Prescription Drugs

Eileen Cook December 20, 2024December 20, 2024 Acetaminophen, Older Adults

Acetaminophen can cause medical complications in people over 60: 4 study takeaways

(By Alexandra Murphy for Becker’s Hospital Review) A study published Nov. 24 in Arthritis Care & Research highlighted serious health

Health Care Finance Health Insurance Legal Actions/Court Decisions Part D/Prescription Drugs PBM's

Eileen Cook December 18, 2024December 18, 2024 Healthcare Finance, Medicare Part D, PBM Industry

How a Duty To Spend Wisely on Worker Benefits Could Loosen PBMs’ Grip on Drug Prices

(By Arthur Allen for KFF Health News) Ann Lewandowski knows all about pharmacy benefit managers, or PBMs, the companies that

HRSA Part D/Prescription Drugs

Eileen Cook December 17, 2024December 17, 2024 340B drug discount program, HHS, HRSA, Medicare Part D, Wholesaler Acquisition Cost

HRSA warns Sanofi over 340B rebate proposal

(By Alexandra Murphy for Becker’s Hospital Review) The Health Resources and Services Administration has issued a warning to Sanofi over

CMS Health Care Finance Health Care Redesign Medicare Advantage Part D/Prescription Drugs

Eileen Cook December 17, 2024December 17, 2024 CMS, Healthcare Costs, Healthcare Finance, medicare, Medicare Advantage, Medicare Part D, Older Adults

5 Medicare Advantage changes coming in 2025

(By Rylee Wilson for Becker’s Hospital Review) Medicare Advantage plans must comply with new network adequacy and health equity standards

Health Insurance Legislative Update Part D/Prescription Drugs

Eileen Cook December 16, 2024December 16, 2024 Anti-competitive practices, Congressional Probe, PBM

Lawmakers probe CVS Caremark over potential anti-competitive practices

(By Alexandra Murphy for Becker’s Hospital Review) House Republicans are investigating whether CVS Caremark, a leading pharmacy benefit manager, violated

FTC Medicare - General Medicare Advantage Part D/Prescription Drugs

Eileen Cook December 16, 2024December 16, 2024 FTC, Insurance Marketing, medicare, Medicare Advantage, Medicare Part D

FTC sends warning to 21 insurance marketing companies

(By Jakob Emerson for Becker’s Hospital Review) The Federal Trade Commission has sent warning letters to 21 companies marketing or

Health Care Finance Part D/Prescription Drugs

Eileen Cook December 13, 2024December 13, 2024 Healthcare Costs, Healthcare Finance, Medicare Part D

Outpatient pharmacy costs outpace total spend by 52%

(By Paige Twenter for Becker’s Hospital Review) Historically viewed as cost centers, hospitals and health systems are increasingly identifying their

Health Care - General Health Care Finance Medicare - General Part D/Prescription Drugs

Eileen Cook December 13, 2024December 13, 2024 Healthcare Costs, medicare, Medicare Part D, Older Adults

Medicare costs are going up next year

Like most things, Medicare costs are going up next year. Medicare Part A and Part B deductibles will increase, along

CMS Health Care Finance Medicare - General Medicare Advantage Part D/Prescription Drugs

Eileen Cook December 6, 2024December 6, 2024 Healthcare Costs, Healthcare Finance, medicare, Medicare Advantage, Medicare Part D, Older Adults

Medicare Spending was 27% More for People who Disenrolled from Medicare Advantage than for Similar People in Traditional Medicare

(By Jeannie Fuglesten Biniek, Alex Cottrill, Nolan Sroczynski, and Tricia Neuman for The Kaiser Family Foundation Published: Dec 06, 2024)